Pomerantz investigates Doximity after revenue guidance misses estimates

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Pomerantz LLP is investigating Doximity regarding potential securities fraud after the company's revenue guidance missed analyst estimates. The stock dropped 23% on May 14, 2026, after management warned of margin pressure from AI costs.

powered bylight_fuzz_icon
42573469

*this image is generated using AI for illustrative purposes only.

Pomerantz LLP is investigating claims on behalf of investors of Doximity concerning potential securities fraud or other unlawful business practices by the company and its officers and directors. The investigation focuses on events surrounding the company's financial guidance for fiscal year 2026 and subsequent market reaction.

On May 13, 2026, Doximity announced its fourth quarter and fiscal year 2026 financial results. The company issued guidance for full-year revenue in the range of $664 million to $676 million, falling short of estimates which stood at $687.04 million. Additionally, Doximity projected adjusted EBITDA between $323 million and $335 million.

Management highlighted increasing cost pressures related to artificial intelligence. The company's vice president of investor relations noted a gross margin impact driven by AI compute costs. CEO Jeff Tangney warned that higher AI investment would weigh on near-term margins.

Following this announcement, Doximity's stock price declined significantly. On May 14, 2026, the stock fell $5.38 per share, a drop of 23%, to close at $18.01 per share.

Financial Guidance vs Estimates

Metric Doximity Guidance Analyst Estimates
Full-Year Revenue $664 million - $676 million $687.04 million
Adjusted EBITDA $323 million - $335 million Not Provided

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is recognized as a premier firm in corporate, securities, and antitrust class litigation. The firm was founded by Abraham L. Pomerantz, a pioneer in the field of securities class actions. Investors of Doximity are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will Doximity adjust its pricing strategy to offset rising AI compute costs in fiscal 2027?

Will the investigation reveal if management withheld information about AI cost pressures prior to the May 13 announcement?

What specific AI investments is Doximity prioritizing to drive long-term growth despite near-term margin compression?

like17
dislike